Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations

NCT03812172 is registered in ClinicalTrials.gov with Mathew S. Maurer, MD as lead sponsor.

NCT NCT03812172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03812172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations
Lead sponsor
Mathew S. Maurer, MD
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
December 13, 2024
Enrollment
646 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid cardiomyopathy, transthyretin-related